Borrelia burgdorferi Johnson et al. emend. Baranton et al. 拉丁名
(ATCC? 55131?) 統(tǒng)一編號
Strain Designations 別名 HB19M
Application 用途 Used to produce vaccine against Lyme disease
Emerging infectious disease research
Vector borne research
Isolation 分離基物 Blood - human
Belgium
Biosafety Level 生物安全等級 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 frozen
Preceptrol? no
Type Strain 模式菌種 no
Comments 注釋 Flagella-less mutant
Growth Conditions 生長條件
Temperature 培養(yǎng)溫度: 37.0°C
Atmosphere 需氧情況: Aerobic
Name of Depositor 寄存者 AG Barbour
U.S. Patent Number 5,436,000
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation 分離基物 Blood - human
Belgium
References 參考文獻 Barbour AG, Bundoc V. Flagella-less borrelia. US Patent 5,436,000 dated Jul 25 1995
human blood